Ping An Biomedical Co. Class APASW

13F holders, Q4 2025 (December 31)
3holders
1new positions
1sold out
1famous investor
$0.50avg. 13F price*

At the end of Q4 2025, 3 institutions reported holding Ping An Biomedical Co. Class A (PASW) in their 13F filings, unchanged from Q3 2025. 1 opened new positions and 1 sold out. The largest holders were XTX Topco Ltd ($12K), Citadel Advisors ($11K) and UBS Group AG ($2K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Ping An Biomedical Co. Class A
CUSIP
G5880S105
Latest filing quarter
Q1 2026

History

Number of 13F holders

01234 Q3 2025: 3Q3 2025Q4 2025: 3Q4 2025Q1 2026: 4Q1 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions1$12K
Exits1$52

All 13F filers, Q3 2025 → Q4 2025: 28,323 shares bought and 42 shares sold, net +28,281 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

XTX Topco Ltd 0.00% New 23,079 $12K
Citadel Advisors 0.00% Add +2.7% 22,886 $11K
UBS Group AG 0.00% Add +6371.2% 4,724 $2K

"% of holder's portfolio" is PASW's weight in each manager's 13F, not the share of Ping An Biomedical Co. Class A the manager owns.